Incyte Corp (INCY)
52.81
+0.10
(+0.19%)
USD |
NASDAQ |
Apr 18, 16:00
52.81
0.00 (0.00%)
After-Hours: 20:00
Incyte Cash from Investing (TTM): -207.68M for Dec. 31, 2023
Cash from Investing (TTM) Chart
Historical Cash from Investing (TTM) Data
Date | Value |
---|---|
December 31, 2023 | -207.68M |
September 30, 2023 | -74.09M |
June 30, 2023 | -85.30M |
March 31, 2023 | -90.35M |
December 31, 2022 | -78.54M |
September 30, 2022 | -123.68M |
June 30, 2022 | -128.03M |
March 31, 2022 | -164.69M |
December 31, 2021 | -207.70M |
September 30, 2021 | -244.38M |
June 30, 2021 | -226.08M |
March 31, 2021 | -220.19M |
December 31, 2020 | -269.00M |
September 30, 2020 | -196.30M |
June 30, 2020 | -169.56M |
March 31, 2020 | -171.45M |
December 31, 2019 | -87.45M |
September 30, 2019 | -93.52M |
June 30, 2019 | -123.68M |
March 31, 2019 | -82.46M |
December 31, 2018 | -86.42M |
September 30, 2018 | -193.33M |
June 30, 2018 | -206.29M |
March 31, 2018 | -239.69M |
December 31, 2017 | -349.98M |
Date | Value |
---|---|
September 30, 2017 | -242.99M |
June 30, 2017 | -222.10M |
March 31, 2017 | -400.06M |
December 31, 2016 | -232.49M |
September 30, 2016 | -201.00M |
June 30, 2016 | -206.27M |
March 31, 2016 | -17.68M |
December 31, 2015 | -105.01M |
September 30, 2015 | -104.00M |
June 30, 2015 | -147.48M |
March 31, 2015 | -149.33M |
December 31, 2014 | -138.44M |
September 30, 2014 | -154.86M |
June 30, 2014 | -97.17M |
March 31, 2014 | -84.33M |
December 31, 2013 | -37.40M |
September 30, 2013 | -17.96M |
June 30, 2013 | -17.21M |
March 31, 2013 | -2.417M |
December 31, 2012 | -1.988M |
September 30, 2012 | -2.627M |
June 30, 2012 | -3.219M |
March 31, 2012 | -2.854M |
December 31, 2011 | -2.501M |
September 30, 2011 | -3.203M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
-269.00M
Minimum
Dec 2020
-74.09M
Maximum
Sep 2023
-155.88M
Average
-164.69M
Median
Mar 2022
Cash from Investing (TTM) Benchmarks
Novartis AG | 5.596B |
MorphoSys AG | -- |
Illumina Inc | -231.00M |
Biogen Inc | -4.101B |
Exelixis Inc | -26.96M |